U.S. markets closed
  • S&P 500

    4,071.70
    -4.87 (-0.12%)
     
  • Dow 30

    34,429.88
    +34.87 (+0.10%)
     
  • Nasdaq

    11,461.50
    -20.95 (-0.18%)
     
  • Russell 2000

    1,892.84
    +11.16 (+0.59%)
     
  • Crude Oil

    80.34
    -0.88 (-1.08%)
     
  • Gold

    1,797.30
    -3.80 (-0.21%)
     
  • Silver

    23.17
    +0.53 (+2.33%)
     
  • EUR/USD

    1.0531
    +0.0002 (+0.02%)
     
  • 10-Yr Bond

    3.5060
    -0.0230 (-0.65%)
     
  • GBP/USD

    1.2296
    +0.0040 (+0.33%)
     
  • USD/JPY

    134.2710
    -1.0350 (-0.76%)
     
  • BTC-USD

    17,014.37
    +71.98 (+0.42%)
     
  • CMC Crypto 200

    404.33
    +2.91 (+0.72%)
     
  • FTSE 100

    7,556.23
    -2.26 (-0.03%)
     
  • Nikkei 225

    27,777.90
    -448.18 (-1.59%)
     

New Strong Sell Stocks for March 11th

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

Digi International Inc. DGII provides business and mission-critical Internet of Things products, services, and solutions. The Zacks Consensus Estimate for its current year earnings has been revised 9.5% downward over the last 30 days.

Independence Realty Trust, Inc. IRT is a real estate investment trust that owns and operates multifamily apartment properties. The Zacks Consensus Estimate for its current year earnings has been revised 3.6% downward over the last 30 days.

IVERIC bio, Inc. ISEE is a biopharmaceutical company that develops novel therapies to treat ophthalmic diseases. The Zacks Consensus Estimate for its current year earnings has been revised 4% downward over the last 30 days.

Palatin Technologies, Inc. PTN is a specialized biopharmaceutical company that develops targeted receptor-specific therapeutics for the treatment of various diseases. The Zacks Consensus Estimate for its current year earnings has been revised 55.6% downward over the last 30 days.

VistaGen Therapeutics, Inc. VTGN is a clinical-stage biopharmaceutical company that engages in developing and commercializing various medicines. The Zacks Consensus Estimate for its current year earnings has been revised 21.1% downward over the last 30 days.

View the entire Zacks Rank #5 List.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Palatin Technologies, Inc. (PTN) : Free Stock Analysis Report
 
Independence Realty Trust, Inc. (IRT) : Free Stock Analysis Report
 
IVERIC bio, Inc. (ISEE) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research